May 9, 2022 –
Chemtron Biotech, Inc. is looking to hire!
April 29, 2016-
Chemtron Biotech has developed an ETG Rapid Test (500ng/ml) for forensic use only. Please contact email@example.com for more information.
April 18, 2016 –
Chemtron Biotech has received FDA 510k clearance and CLIA Waived for Low Cutoff Drugs of Abuse Tests. Chemtron can now offer AMP300/AMP500/BAR200/BZO200/COC150/MET300/MET500/PPX300 in cup or dip card format. Chemtron has a total of 15 Drugs CLIA Waived including lower cutoffs to satisfy the always changing market needs.
April 17, 2015 –
Chemtron Biotech has received FDA 510k clearance and CLIA Waived for 14 Drugs of Abuse Cup Tests. The Chemtrue DOA Cup is a split specimen cup that offers quick results at 5 minutes. It is manufactured in the U.S.A.
January 1, 2014 –
Chemtron Biotech has opened a brand new state of the art 14,000 sq. ft. manufacturing facility in San Diego, CA USA. This new facility has full in-house manufacturing capabilities for the entire Chemtrue Drugs of Abuse product line.
May 20, 2013 –
Chemtron Biotech has received FDA510k clearance for hCG urine and hCG urine/serum tests.
November 29, 2013 –
Chemtron Biotech has received FDA 510k clearance and CLIA Waived for 12 Drugs of Abuse tests: AMP1000, COC300, THC50, MAMP1000, MOR300, PCP25, BZO300, BAR300, MDMA500, MTD300, OPI2000, and OXY100. Chemtrue’s non-flooding dip card can be offered in any configuration, up to 7 parameters.